Facilitated By

San Antonio Medical Foundation

A PHASE II STUDY OF LOW DOSE ARSENIC TRIOXIDE IN PATIENTS WITH MALIGNANCIES AS A POTENTIAL CHEMOTHERAPY PROTECTOR

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Ha,Chul Soo
Funded by
CHEMO PROTECTIVE R&D CORP.
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Cancer